How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort

Diabetologia

Volumn 55, Issue 6, 2012, Pages 1651-1659

  Rahman, M ^a   Simmons, R K ^b   Hennings, S H ^b   Wareham, N J ^b   Griffin, S J ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Ely; Health outcomes; Screening

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANXIOLYTIC AGENT; HEMOGLOBIN A1C;

ADULT; ANKLE BRACHIAL INDEX; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GENERAL PRACTICE; HEALTH ASSESSMENT QUESTIONNAIRE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; VISUAL ANALOG SCALE; WELLBEING; AGED; EARLY DIAGNOSIS; ECONOMICS; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT; STATISTICS;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84862658042     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2441-9     Document Type: Article

References (42)

1. International Diabetes Federation Diabetes Atlas, 4th ed 2009. IDF, Brussels
2. Simmons RK, Echouffo-Tcheugui JB, Griffin SJ (2010) Screening for type 2 diabetes: an update of the evidence. Diabetes Obes Metabol 12:838-844
3. Echouffo-Tcheugui JB, Sargeant LA, Prevost AT et al (2008) How much might cardiovascular risk be reduced by intensive therapy in people with screen-detected diabetes? Diabet Med 25:1433-1439
4. Family Heart Study Group (1994) Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ (Clinical research ed) 308:313-320
5. Imperial Cancer Research Fund OXCHECK Study Group (1995) Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ (Clinical research ed) 310:1099-1104
6. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T (2002) General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. J Fam Pract 51:546-552 (Pubitemid 34602990)
7. Eborall HC, Griffin SJ, Prevost AT, Kinmonth AL, French DP, Sutton S (2007) Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ (Clinical research ed) 335:486
8. Kahn R, Alperin P, Eddy D et al (2010) Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 375:1365-1374
9. Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15:815-819
10. Williams DR, Wareham NJ, Brown DC et al (1995) Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30-35
11. Forouhi NG, Luan J, Hennings S, Wareham NJ (2007) Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med 24:200-207 (Pubitemid 46174945)
12. Townsend P, Phillimore P, Beattie A (2004) Health and deprivation: inequality and the north. Croom Helm, London
13. Carter SA (1968) Indirect systolic pressures and pulse waves in arterial occlusive diseases of the lower extremities. Circulation 37:624-637
14. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289 (Pubitemid 24324972)
15. Rahman M, Griffin SJ, Rathmann W, Wareham NJ (2003) How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med 20:368-374 (Pubitemid 36605621)
16. Canadian Diabetes Association (2008) Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 32
17. Rose G, McCartney P, Reid DD (1977) Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 31:42-48 (Pubitemid 8066480)
18. Rose GA (1965) Ischemic Heart Disease. Chest Pain Questionnaire. The Milbank Memorial Fund quarterly 43:32-39
19. Blackburn H (1969) Classification of the electrocardiogram for population studies: Minnesota code. J Electrocardiol 2:305-310
20. Stevens RJ, Kothari V, Adler AI, Stratton IM (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671-679 (Pubitemid 33135349)
21. Ware JE SK, Kosinski M, Gandek B (1993) SF-36 Health survey. Manual and interpretation guide. The Health Institute, New England Medical Center, Boston
22. The EuroQol Group. (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands) 16:199-208
23. Holman N, Forouhi NG, Goyder E, Wild SH (2011) The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Med D. Diabet Med 28:575-582
24. Chen TH, Yen MF, Tung TH (2001) A computer simulation model for cost-effectiveness analysis of mass screening for type 2 diabetes mellitus. Diabetes Res Clin Pract 54(Suppl 1):S37-S42 (Pubitemid 32907245)
25. Goyder EC, Irwig LM (2000) Screening for type 2 diabetes mellitus: a decision analytic approach. Diabet Med 17:469-477 (Pubitemid 30471343)
26. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577-1589
27. Patel A, MacMahon S, Chalmers J, ADVANCE Collaborative Group et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560-2572 (Pubitemid 351831357)
28. Kind P, Dolan P, Gudex C, Williams A (1998) Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ (Clinical research ed) 316:736-741 (Pubitemid 28121072)
29. Adriaanse MC, Dekker JM, Spijkerman AM et al (2004) Healthrelated quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabet Med 21:1075-1081 (Pubitemid 39389218)
30. Diabetes UK. Position statement. Early identification of people with type 2 diabetes. June 2006. Available from www.diabetes.org.uk/About-us/Our-Views/ Position-statements/Early-identification-of-people-with-Type-2-diabetes/. Accessed 1 Feb. 2011
31. Campbell SM, Roland MO, Middleton E, Reeves D (2005) Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study. BMJ 331:1121
32. Doran T, Fullwood C, Gravelle H et al (2006) Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 355:375-384 (Pubitemid 44127540)
33. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393 (Pubitemid 36159355)
34. Manley S (2003) Haemoglobin A1c-a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182-1190 (Pubitemid 37265697)
35. Tuomilehto J (2000) Controlling glucose and blood pressure in type 2 diabetes. BMJ (Clinical research ed) 321:394-395 (Pubitemid 30609438)
36. Genest J, Frohlich J, Fodor G, McPherson R (2003) Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 169:921-924 (Pubitemid 37372465)
37. de Fine ON, Holstein-Rathlou NH, Siersma V et al (2004) Peripheral vascular disease is associated with reduced glycosuria in newly diagnosed type 2 diabetic patients. Diabetes Metab 30:269-274 (Pubitemid 38917457)
38. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC (2003) Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 20:988-995 (Pubitemid 41701479)
39. Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ (2003) Foot complications in type 2 diabetes: an Australian population-based study. Diabet Med 20:105-113 (Pubitemid 36269651)
40. Simmons RK, Rahman M, Jakes RW et al (2011) Effect of population screening for type 2 diabetes on mortality: long-term followup of the Ely cohort. Diabetologia 54:312-319
41. Morgan CL, Currie CJ, Peters JR (2000) Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 23:1103-1107 (Pubitemid 30616796)
42. Forouhi NG, Merrick D, Goyder E et al (2006) Diabetes prevalence in England, 2001-estimates from an epidemiological model. Diabet Med 23:189-197